ArticleSurgical endoscopy2026
Minimally invasive versus open liver resection for hepatic alveolar echinococcosis within a disease-control oriented surgical strategy: a single-center retrospective study.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe surgical strategy for hepatic alveolar echinococcosis (AE) differs from that for typical malignant tumors, as treatment is not solely determined by the feasibility of complete (R0) resection. While complete resection remains the preferred goal, cytoreductive surgery combined with albendazole therapy is considered in selected cases. The role of minimally invasive surgery (MIS) within this disease-control oriented strategy remains unclear.
methodsWe retrospectively analyzed 126 patients who underwent liver resection for hepatic AE between January 2010 and March 2026: 87 underwent open surgery and 39 underwent MIS. Perioperative and disease-control outcomes were compared, with propensity score overlap weighting used to adjust for baseline differences.
resultsThe MIS group had smaller lesions and less advanced disease. Operative time was similar, whereas blood loss, Clavien-Dindo grade ≥II morbidity, severe morbidity, and hospital stay were lower in the MIS group. After overlap weighting, MIS was not associated with an increased hazard of disease progression (hazard ratio 0.47, 95% confidence interval 0.07-3.22; p=0.44). An adjusted hazard ratio for overall survival was not estimable because no deaths occurred in the MIS group.
conclusionsIn selected patients with hepatic AE, MIS was associated with favorable perioperative outcomes. Although no increased risk of disease progression was detected after adjustment, limited events and shorter follow-up preclude conclusions regarding long-term equivalence.
Indexed as
Identifiers
42686843What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.